Anthem Biosciences Limited
ICICI Prudential Life Insurance bought 12,08,379 shares of Anthem Biosciences for ₹90.00 Cr at ₹744.80 apiece in a block deal.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
Joint venture between ICICI Bank and Prudential plc. Total AUM in excess of Rs 3.2 lakh crore deployed across linked, participating and non-participating funds. CIO Manish Kumar has run the equity book for over a decade, with style biased to quality large and mid-caps. Active across primary and secondary markets through ULIP and group fund mandates.